To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Localized controlled drug… - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

Localized controlled drug delivery from mesoporous implants

Conference paper
Authors Johan Karlsson
Necati Harmankaya
Anders Palmquist
Ryo Jimbo
Anna Martinelli
Gustav Sundell
Mattias Thuvander
Mats Halvarsson
Pentti Tengvall
Martin Andersson
Published in Technical Proceedings of the 2014 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2014. Washington, DC, United States, 15-18 June 2014
ISBN 978-1-4822-5827-1
Publication year 2014
Published at Institute of Clinical Sciences, Department of Biomaterials
Language en
Subject categories Chemical Sciences


Mesoporous materials possess both a well-defined topography on the nanometer scale, and they may serve as hosts for drugs. In this work, titanium implants coated with mesoporous TiO2 thin films have been evaluated both in vitro and in vivo. Material characterization showed that, long-range ordered mesoporous TiO2, with a pore-size of 6 nm, and a narrow pore-size distribution were obtained. An in vivo study demonstrated that the films were robust enough to withstand the implantation procedure. The in vitro apatite formation experiments showed that formation of apatite was higher on the mesoporous surface compared to its nonporous counterpart. In a separate in vivo study, two osteoporosis drugs, alendronate (ALN) and raloxifene (RLX), were immobilised into the nanoporous oxide films. The in vitro drug release tests carried out showed a sustained release of both drugs. The osteogenic response after 28 days of implantation of the drug-loaded implants showed a significantly improved bone fixation.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?